Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-26T05:08:38.388Z Has data issue: false hasContentIssue false
  • English
  • Français

COVID-19 related sleep disorders and the mental health

Published online by Cambridge University Press:  01 September 2022

S. Kryzhanovskiy ,
M. Samushia ,
T. Berishvili ,
S. Chorbinskaya  and
V. Shmirev
S. Kryzhanovskiy
Affiliation:
Central State Medical Academy of Department of Presidential Affairs Moscow, Russia, Scientific Department, Moscow, Russian Federation
M. Samushia*
Affiliation:
Central State Medical Academy of Department of Presidential Affairs Moscow, Russia, Scientific Department, moscow, Russian Federation
T. Berishvili
Affiliation:
Central State Medical Academy of Department of Presidential Affairs Moscow, Russia, Scientific Department, moscow, Russian Federation
S. Chorbinskaya
Affiliation:
Central State Medical Academy of Department of Presidential Affairs Moscow, Russia, Scientific Department, moscow, Russian Federation
V. Shmirev
Affiliation:
Central State Medical Academy of Department of Presidential Affairs Moscow, Russia, Scientific Department, moscow, Russian Federation
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

COVID-19 affects nervous system and the mental health of patients.

Objectives

The aim of the study was to determine the prevalence of depression, anxiety, and insomnia among patients hospitalized with COVID-19 in order to understand mediating factors and inform tailored intervention.

Methods

To the study patients with mild and moderate COVID -19 were included. It was no included patients with diagnosed psychiatric disorders. It was conducted an interview, including using telemedicine technologies, assessed HADS, MFI-20, Pittsburgh Sleep Quality Index (PSQI) questionnaire.

Results

It was analyzed the data of 119 patients, 34% patients was female, mean age 58,7±11,1 range 47 to 69 years. Anxiety-depressive symptoms were observed in 33/119 (28%) patients by HADS scale. Clinically significant anxiety and depression were seen in 11% and 4% of the patients, respectively. In 13% patients was observed as anxiety as depression. An increase in the MFI-20 scale (more than 20 points) was found in 87 (73.0%) patients, sleep disorders in accordance with the PSQI questionnaire was recorded in 32 (27.0%) patients. Sleep disorders were manifested by dissatisfaction with sleep quantity or quality that is associated with difficulty falling asleep. All patients have asthenic symptom.

Conclusions

It was noted that in most patients with COVID-19, along with a depressive and anxiety disorders, an asthenic symptom complex, sleep disturbances are recorded. The choice of the medical intervention should be based on the severity of the violations identified taking into account the side effects of the prescribed drugs, drug interactions and somatic status of patients

Disclosure

No significant relationships.

Keywords

DisorderssleepCovid-19Depression
Type
Abstract
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S484 - S485
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.